Stay updated on Lanadelumab SubQ Delivery Devices Bioavailability in Healthy Clinical Trial
Sign up to get notified when there's something new on the Lanadelumab SubQ Delivery Devices Bioavailability in Healthy Clinical Trial page.

Latest updates to the Lanadelumab SubQ Delivery Devices Bioavailability in Healthy Clinical Trial page
- ChecktodayChange DetectedThe ClinicalTrials.gov site footer revision changes from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check28 days agoChange DetectedA banner announces NIH website changes and explains that federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference0.8%

- Check35 days agoChange DetectedThe site footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check42 days agoChange DetectedThe site’s displayed revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check63 days agoChange DetectedA new revision entry was added to the record history: the latest version is v3.7.0, updating from the previous v3.6.6. This represents an updated version of the study record for provenance.SummaryDifference0.1%

Stay in the know with updates to Lanadelumab SubQ Delivery Devices Bioavailability in Healthy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanadelumab SubQ Delivery Devices Bioavailability in Healthy Clinical Trial page.